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1. INTRODUCTION 
Hormonal activation of adenylate cyclase requires 
the specific interactions of an agonist-occupied recep- 
tor, tile guanine nucleotide.binding protein (G, or Gd 
and the catalytic unit 'C'. hlformation from receptors, 
which stimulate adenylate cyclase, is mediated by G,, 
whereas negative impulses are transduced to 'C' via G~ 
[1,2]. Multiple subtypes of Giot have been identified 
from molecular cloning studies [3-5], viz. Gil, Gi2 and 
Gi3. Each of these polypeptidcs i a substrate for per- 
tussis to×in-catalysed ADP-ribosylation [6,7]. The 
species of G~ involved in the inhibitory arm of the 
adenylate cyclase cascade renmins unclear, though G~2 
has been demonstrated to be a potential mediator of 
adenylate cyclase inhibition in some cells [8,9]. 
Among the components of the adenylate cyclase 
system, G proteins could be a locus for permissive hor- 
mone regulation [10], a phenomenon which has been 
observed with thyroid hormone [11,12], glucocor- 
ticoids [13] and steroids [14]. We have previously 
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reported that at specific stages of gestation whM~ are 
characterized by important fluctuations in the relative 
concentrations of estrogen and progest,:rone, the tat 
myometrium exhibited marked alterations in adenylate 
cyclase stinmlability [151. At the onset of gestation, 
there was a progressive attenuation of adenylate cyclase 
activation in response to different stimulatory agor'.ists, 
with minimal responses being observed at midgestation 
(day 12). The advanced stages o f  gestation were 
associated with a progressive restoration of ader~ylate 
cyclase stirnulability with a full responsiveness before 
parturition (day 21). Of interest were the findings that 
pertussis toxin treatment of day 12 myometrium 
resulted in a reversal of the attenuated cyclic AMP 
responses uggesting that the inhibitory protein G~ was 
involved. Recently, using varied o~ subunit-specific an- 
tisera, we reported [16] the absence of Gdce and the ex- 
istence of both Gi2a, and a novel form of Goot in the 
estrogen-dominated rat myometrium (day 0). The pre- 
sent study focuses on the immunological characteriza- 
tion and the modulation of the (3i proteins in rat uterus 
during gestation. 
2. MATERIALS AND METHODS 
2.i,  Antibody characterization 
Each antiserum was produced in a New Zealand white rabbit 
following the procedure previously recorded [17]. SG1 is an ant,pep- 
tide antiserum produced against file synthetic decapeptide 
4 PulJlished by Elsevier Science Publishers B, V. (Biomedical Division) 
t. ~h l l l~-  , ] " t ,  !~,~tli!!%<~ I I I l l ' .  i I 1 I I  It <, l~iit~+~I~ I ' !V l  
I~1  t#;t~tl~It~<ltt l l " i  I l h t l  .~l l ! i i~tt l l t l t  {~llll il},l ~,|lli t E,l l l~lTll l l l i~ ( i l  l i ke  
I l ' i>l.~ll l l  l i t  | ,11!~1 I ' ;  ~} ,~ l l i l l~ f l l l l f{  | I ~ ~'~! l l . i l l t~ |  , l#.. l}, i t f  I l~l l l l t~,#'~ 
i~fpt~l~ < tt l i t t .A , l ) 'd)~l  I/ t-l-J~If¢tftt'Iti l i i~l{ I+l Glfitlii~..llci~!f I/iO I~:# l. l  
( i . :+ i .  ,t~t,I " tl+~'.lflm f~t (h,7~ [ l " l  . l l(tl l it~fltl i l  l l t l  ~,~t l.tt~q"l ,l~t,tllil~ 
1~7|lt l l l l , l l  ~le~lt>~:=i>licl~" ~lf Ih,~ ,~ t l l | l t l l l l l  ~ f  ( t . I  f i l l  %, t l l l l~ I t l l l l  .:,~,il 
~f,lfltliti/l~l| d~'Clt~plfd~" ~l( I11¢ J I  ttilltlll~t .1,1kl 1 ¢~;~1{ in.f¢+i I]~lllt J I il~,ll 
~ tnl,~i, ll;l~'~ I I  ~It 
.~<~ /Tt l l l i  + ~'l t t l l , ' i~i l / l l l  i~#lit 1 It/t'#t/,ht'iirli~" t.~wefJtlt,ttl~slt 
t<'l¢l'l ~,t+,~1¢ tt|~l,t l l l i t l  f l~l l t  i t l l l l l l l l i l ig l ' l l l~lft' lt, l lf l=llt. ' i l lGil f ; i l l  i l l  
f l l l l t ;  I~l¢~,lI.iltl f . l l l  ill cltfl' i 'f¢lil 111t71~ ~lf leA'tl;llltlll ~ l )~ l l i f l f i l i i l t  ",l.ll 
prep,t ied l i ce  o f  tile ¢lidOlr~¢ll it i l i l  il., in I I$ .~ni .  t'ttlt[~.- l l l¢ l t lbf ,~l l~ 
• A;I~,- l l l t l . l i l l l  ' t-l.lllli dif fcft=ll l  tl i%onl¢Iri; l| I~,ll~'tl;Ir;Illlllli ,;II ,t f= I11t Ill 
i i t~I. (:~ lt~lc I l l ¢ |nb f , l l l~  f f~t¢ l io l l " i  W~'t¢ p l l 'p i I f i~ , l  l l~Hn f , t l  b r i t in  ;ttl~,l l'~tt 
~,It111~1'~ c'te ~tlbj¢~;ied io N.i~ihy in; l ld i i l id l ,  l i¢ . l l l i ien l  ;i,l in I I t ] ,  
t~eryhltil id¢, O. 1 5% Ifi'~aefyl->~lllide (v,;~,)) ~',!:rl l l lt l l l  ill IOt) V. Ih'ot¢~n'~ 
~,~,ele Ir~ll;f¢l'l'Cll to liill'OCelhlhi~c ;111¢I I~lo~ked fPr *i'C) II1ill ill J';'(_' 
WiIII I~'~ ¢¢h~lin in 'l'ri~.htlffcred ~nliti~ (TII~) 1.~I] mM rri~.l IUI. pl I 
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~¢;inller D¢lag~l C I ) .60,  ( 'Ol lt l 'ol  C~l')Cl'ilnenl~ (ao l  .~llOwlll e~l:lbli,~hcd 
Il i ; l l  fo r  cileh ;ni l i~cri l l l l  l l ic in icn~i ly  o f  l i ib¢l inl l  o f  the ¢orrespondinl- I  
hated was d i rect ly  prOl~ort ionl l l  IO I l le alllOnl~il o f  inyolnelr i~d lnenl-  
I'~I'i111¢ i ' lr0lein u.~ed in lhe assay (see Fig. 2 fo r  e~al l lple),  
I. 141 ~,1"1 IX, 
~,l~c It;~,~- I't%:Clt[[ T ~,ltOY~'l|, ;h i l l  I';I,l tl1~Ot~|t'|l'i~,1t[ I|'!l'l|~t, 
rlirlh~.r ilhv.li'.~i~d in l:i~, 11~ ;lJld hi. |ruder SI)S.I'A(iI! 
~:o|l~Jiliol|'~ 11J,>% acr)l~mlid¢, l). I~"'~, bi~il~ryl~mide,) 
l l l~ ,  , I , . I i ,  | l i l t  t ¢i%,) t . ' i l l t  bC  ~|cl|ie~-¢d. t~tlili~iCl'tllll H(; i l ,  
capable of ini¢l'~cdl}i~ ill~ lhe ~ .~ubl|nil~ of  ( i , I  |1lid 
~i,2. idcni i f icd ¢~vo I X~lyl~ptidc~ of 41 kl)a (prcdomi. 
l|;||lt~ alid .tO kt);t i|l rat bt'~dn me||~bt'alie~ (Fig. la}, [|| 
~:o l l l l ' ;~!  n l} '¢mtct r i~ l l  IttCll i l . l l ' i l l l ,~'~ co i | l i l i t l cd  on ly  ;i 
~ml:le l°orli~ of (.i,. wl|idt I|liBilIilc(l wilh ;| nlobilily 
~imilm' to (i,2., {.It) kl).} in r:il bi'Idn (I"im ht}, U~ii|il 
¢h¢ ~clccl ire (i,2~ :itili~c|'uill I..E2 It "/I, we idcniificd on- 
lY low I~v¢I of m| hnlllui|orcaciivc i~olyi~cptidc in rat 
briiill ai|d confirmed lh¢ identity of the rat myomcii ' ial  
S( i l .dct¢¢lcd (i, a.~ Gi2 (Fill, Ib). 
r~o detect the pot¢l|ti~d pl'¢.~¢i|cc of another Gi pro- 
l¢ i I I  ill ral =nyometrium, we employed the ant|set|til l 
i311, which =s directed at.~ainst he C-|ermined dccapcp- 
tide of ¢~,3 and identified only (.ii3~r [18]. immuaob lo f  
ring of  rat rYlyomctrami with I3B (Fig, lc) led to the 
idea||fie:it|on of  ~,~ sinllle polypcptide of 40.5 kDa, 
which mittr;Itcd with ll~e same apparent molecular mass 
as ¢~i3, present in C6BUI cells [18] and slightly retarded 
compared to m2, 
We used il~e specific antisera, described above to in- 
vcstigate the expression and an eventual ¢tuantitiltivc 
change of Gi2 atzd Gi3 in rat myometrium durin8 gesta- 
tion, Fig, 2 displays an immunoblot of rat myometrial 
membranes derNed from different stages of gestation 
Gi2~ t . . . .  
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Fig. 1. Identification of G~ proteins of rat myometri~m us G~2 and G~3. (a) Membranes from either rat brain (B) (lO0/zS) or estrogen-treated 
rat myometrium (M) (50/~g) were resolved and immunoblotted as described in section 2. The blot was developed using antiserum SGI (1:200 
dilution) as the primary reagent, (b) A similar ezperiment was performed e~cept that the 13rimary antiserum was a l :200 dilution of LE2. (c) 
Membranes from either rat brain (B) (100 #g), rat glioma C6Bu! (100 pS) or estrogen.treated ratmyometrium (M) (200/~g) were resolvea nd 
immunoblotted using antiserum 13B (1:200 dilution). 
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l'b:, 2. I)¢t¢ctiott and t.odut,~tiott of tile ++ +~tl-,tl~it of ¢,;,2 it+ r+tt 
ItI}'~II~|fiL|ll~ , tl thffercl~l qal~e'~ of ge,qat~,',n, llifl'cf¢~t ~mi~.',illt~ of
¢111+.I¢ rllt2it~lll+lll¢'+ (51 } tiP+, lOl l j tg, or 20{)i+I~1 l+r~llI f,~| m~O111¢lritltli 
id ly O. day 12 o+ + day 21t ',~ct,: t+uu on SI)~,q~0|~;wr)tamid¢ ~.:el, 
¢l¢<trobh~tted and developed with SGI :,lr~li~,crtim, ~1: ~i)t) dihtliolt) ;it 
,d¢,.;tibed ii~ ~¢~:tioh 3+, 
(0, 12 or 21 daysL i'esolvcd by SI)S-I'A(;[- attd staitlcd 
with antiserum SGL. SG 1 recognized a single polypep- 
tide of 40 kDa, described its Gi2gr, it was interesting to 
note tl~at for different amounts of proteins up to all 
aniottnt or' 200/~g, labelling of Gi2xr was more imense 
in membranes of niidg~statiott (day 12), sigtmlling the 
presence of a higher quantity of  Gi~e in these mcnt- 
branes compared to day 0 and day 21. Indeed, den- 
sitometric scanning o f  the immunoblot indicated that 
the level of the rv subunit of Gi2 was increased in day 
12 compared to day O by 160 -.t: 20% (mean ± SEM, n 
= 6), At the end of gestation (day 21) no significant 
change was observed compared to day 0. lmmunoblot- 
ting exporiments with the antiserum LE2, which 
recognizes only o¢i2 (Fig, 3), revealed a single band in 
(kDa)  
- -97 
- -68  
~*ot~q~l¢cd tO ~l,ty l )b~, 151) r 11)'~% !lVt¢;II~ .~ hl'M, I t - ,  
i), 
I);H~t ill Fig, 4 illt|~:r;al¢ illtmtmobh~tthl.g of t'at 
myomctcial mcmbrat~c~ I't'ov~ day,~ 11, 12 luld 21 ~'~ilh 
17~11 .tll|i~71'Ult}. ~k*'Z' d¢||1oll~ll'itlc Ili itt (i+.IIo¢ t,'~ ~Ii+, ¢~pt'c~'- 
cd  th l~) t i~hot | l  the  g¢~lat i tm iOtd ft . |rth¢l ' l l i , J fc th~tl 
;lll|Ot, l tt |~ ~.)f ~,t,~ tl¢~.t'c;tscd ~ i th  ad'~all,di l lg gC~|i|tiOtlJ 
(Fig, 4), (Ollipitf¢~:l tO dIt/ (l !++!c!}~h,,.HlC~,, "i,,.llllC 35 .~ 
IIW,~ dc¢~'e~" at midgcstalitm and ~Olll¢ +75 t ~'*~ 
tlcercasc ~li the clid of gexl,ttion svcr¢ tlct¢clctl I~* dcp.. 
sitomctric ~:uhnio~ (MCBI| t + SFM, n ,- 4), 
As  (,; pt'olchls ;tt'c usttally cousidcrcd to ~'xi~t a~ ;~ 
hctcrotrini¢;i~: complex , +r :~ +)'~,, the stitttt,~ of tlt¢ .,3 
sttl~units dt;i'ing g¢,~t'ttiotl wcrc iuvcstigatcd hy int- 
nltmoblotting witlt antiscruu )]NI, which t'ecognit, es 
both the 35- and 36-KDa+M+ forths of ~$ sltbutlits [19], 
~¢NI antisc|'utll detected a J3/36 kDa doublet ill vat 
myometfium, as well as itt the brain nletlfl~ratles 
(Fig, 5), with a tgreatcr intensit~ of labeling for the 
higher molecular mass form. This donblet was prcsctu 
in rnembranes derived from ull stages of gestation, 
Densitotnetfic straining of the imnltmoblot indicated 
that the level of both 35/36 kDa peptides was increased 
in day 12 compared to day 0 by 200 :t- 150:'0 (mean ± 
SEM, n ,= 3). "Thus the midgestation phase was 
characterized by increased levels of fl subtmits, cort- 
comitant with the elcwtted levels of Gi2x.v, 
~, D ISCUSSION 
Our previous report [15] demonstrated that in rat 
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Fig. 3. Evidence for a, i2 modulation during gestation using specific 
antiserum LE2, Membranes from day 0, day 12 and day 21 rat 
myometrium (100a/~) were resolved and immunoblotted in the 
presence of LE2 antiserum (1:200 dilution), Experiments were 
carried out as described in section 2. 
21 12 Od 
Fig. 4. Det¢ctio~ and modulation of G~3ce in rat myonlctrium durin8 
gestation. Different rat myometrial memOranes (day 0, day 12 and 
day 21) (200/zg) were resolved and immunoblotted as described in 
section 2, The blot was developed using 13B (1:200 dilution) as 
primary antiserum. 
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I;i ~. ~. ~tilltl's t,f the +,l' stl|)tlt~,it~, o f (i~i'~l'O|cil'l~. d~llillF-, g¢~.[illiOl| [1o111 
I'a: l it)Oll lCll ' lt l l lt .  MCll lbr; l l lC' i  titS')litd~ troll+ e i ther  ral  b ra in  0h ' |  or 
I%|i I I|¥O|llCll ' Ithl| {([;~)'t 1}, 12 ;l l ld 21) v.Cl'¢ rc,~ol~cd it l ld 
tt'v,l+~ UltOt'~Jolled tl+it+g ;,+lHi+crtlm dN I ( l : 2t~:) dihl l iOt~) ;~s dc+cr ibcd  in 
scClioll "~, 
stimulability +it midlgestation (day 12) could be revcrsed 
by pertussis toxin.treatment, indicating the involve. 
merit of G+ in this event. In order to characterize and 
tentatively evaluate the various forms of Gi, We itn- 
munoblotted myomctrial membranes with different an- 
tibodies directed against distinct ¢vi subunits under 
SDS-PAGE conditions in which good resolution of 
~hese subunits can be achieved. 
In the present study, we confirmed that estrogen.. 
treated rat myonictriuna (clay 0) did tier contain dctec- 
table levels of Gila. and that SGI as well LE2 an- 
tibodies recognized the same polypcptide, which can 
thus be identified as G~2~x. Additionally, the use of 13B 
antiserum specific for G~3c¢ led to the identification of 
G~3ce in rat myomctrium. It is worth noting that 13B 
seems to detect an extremely weak signal in brain mem- 
branes of a polypeptide which migrated identically with 
rat brain Go~Z. The slight cross reactivity of the anti 
Gi3ce antisera with the ce subunit of Go in rat brain has 
previously been recorded [22] and could be explained 
by the fact that oei3 and ~o share a C-terminal tyrosine 
residue which is absent from ceil and o'i2. It remained 
possible that the amounts of Goce present in rat 
myometrium [16] are sufficiently low that it is impossi- 
ble to identify Goce in myometrial membranes with I3B. 
Further evidence of the molecular identity of Gi2ff and 
Gi3a,, is that the a, subunits of ~iz unu ~i~ xounu in 
myometrium igrate identically with the equivalent 
forms of Gi2ce in rat brain and of Gi3ce in C6BU1 cells 
[18,23]. So far, these results provide evidence for the 
d~:,+.~ilwd I~,~++t i~+tlti ,~i I L  l i t  ~)~.t!O~++'lttl~.~ill~t~l r i l l  
I.~-l++tt+llllCllI `; |~+i'!'I~WIII+.7~I IIIl+~l+~t llt~" ".~111~+' Ctlll+di|l+Oll'~ 
',~. ilh ll!~.'l!lll+l'ilil~'~ i'l't.~ll1~ 0.I'~ ~i II, I ~ ir|ll~I ~ I illdk'~llcd II~ 
qlhdil4~li~.c ~ilhllll~c~. ill lhc I~,IIO,~ o[ ,, ,, l~tol¢ilP~, thai i~,. 
u~Idci¢~'l~bh" Ic~.cl of  ¢,i,l,, i1~id l'qC.Wl~'c of  bo!h  (,i,2+~, 
• ~i~| l i,),~, ill dli'l'cr~IH ll'~'l~Ibl'illl¢ l~1'¢|~iri|llOll~., Pill-- 
li~+'dlitrl)+ l¢,~'vi l l l I  ~,~+~1'¢ lh¢  t l i l ; t l t l i l i i [ iv~,  Ill0+dil'i++*illlOn~ 
ob+~¢l~cd d~r im +. g¢,+htliOlt ill lhc Ic~cl~ ~1 t i ,2 .  and 
(i,.L~ ~+hich addit ioual ly  al~l~¢m*cd to I~c di f f¢[¢nt ia l ly  
I'¢t~HliHcd Ih:lv;ilol'~iclri~ ~+~;itl|ltlllb + o f  inl l l l t lnoblol~ 
~h~¢d t l l i l l  Ill++- : ! lnOt l l l l  tM (i~.1~. p~+ogrcssi~-cly d¢~l'¢a~.~ 
c.d w i th  ; idv i l lwI i l t~ , t-~.{++lilliOl|, ~h i l~ l  a i l l i l r kcd  In+dr+:it+ic 
of ~.i,2,~ Icvd wn~ ~rilic;dlff , f l~crvcd ~, day 12. +,villi ~ 
l'C.lUrll to day t] Yahoo at the ~lld o|" l:¢~tiltiol). It ~ im- 
midgc~4;~tion ¢oiu¢idcd ~.'ilh the ab~{11c¢ of ;~dcnylalc 
~y~lasc slmmlal~ilily I 151. l"urlhcrnmr¢, lhc decrease of 
(i,2,1 in day 21 111youlCll'i~,llll IO le'~'cl~ siulilltr to tho.s¢ 
l'ouml in day 0 prcpari~tions, coincided with the 
recovery oi" I+ull adc~lylat¢ cy+lilsc s l imulabi l i ty  at term 
[151. "lh+ denla l l s t l ' ;a tcd  11|¢1'+~.1s¢ i l l  +ri 9 May  thl |+ pro -  
vidc ;~ reasonable illtcrpret;,ition for the enhanced in- 
hibitory pathway revealed at midgestation, particularly 
a~ wc have previou.~ly dcl l lot lstratcd that pertussis toxin 
treatmct;t of day 12 I11yoMeIFiLIl~i iS able to restore the 
stinwl0,bilit yof adc~ylate cycl;sse [ 15], It is further con- 
ccivablc to propose that Gi2~r may be the mediator of 
:tdenylate cychtse inhibition in the myonaetriuna. Our 
tentative interpretation ts reinforced by recent reports 
demonstrating that G~2+r was preferentially implicated 
in adcnylate cyclase iuhibition induced by 
,¥.,-adrcnergic and ,$-opioid receptor activation in 
platclets [9,24] and NG108.15 cells [8]. Interestingly, 
both cell types, like the myometrium, are devoid of 
Gila, and possess both Gi2q, and Gi3~e. The progressive 
decline in Gi3~e level with advancing estation may cer- 
tainly underlie an important phenomenon, however it 
seems difficult to implicate it in the pattern of the 
altered adenylate cyclase pathway: first, the day 12 
myometrium was associated with both a decrease inGi3 
level and an attenuated adenylate cyclase stimulability 
and second, despite the serious decline in Gi3~, the in- 
hibitory pathway of adenylate cyclase was normally ex- 
pressed in the myometrium near term [15,25]. The 
functional role of G~3ce remains to be clarified. 
Immunodetection by antiserum fiN1 demonstrated 
the presence of 35/36 kDa Mr forms of D subunits in 
rat myometrium at different stages of gestation. The 
pattern of/~ subunit modulation was similar to that 
observed for Gi2ce: the intensity of labelling in day 12 
myometrium was more pronounced compared to day 0. 
The simultaneous increase oi'~3 a~d G~2cr subunits at 
midgestation might be expected if the regulation of the 
expression of the different subunits of G proteins are 
coordinated to keep the ratio of o:/~ in the same range 
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